CHRONOSOME : revenue, balance sheet and financial ratios

CHRONOSOME is a French company founded 18 years ago, specialized in the sector Autres activités liées au sport. Based in SAINT-ANDRE (73500), this company of category PME shows in 2021 a revenue of 7 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CHRONOSOME (SIREN 503044349)
Indicator 2022 2021 2020 2019 2018 2017 2016
Revenue N/C 7 000 € 30 350 € 28 550 € 19 450 € 27 950 € 32 550 €
Net income -2 153 € 5 303 € 2 272 € 1 657 € 743 € 1 830 € -17 €
EBITDA -2 153 € -1 428 € 2 945 € 2 103 € 3 165 € 4 272 € 1 740 €
Net margin N/C 75.8% 7.5% 5.8% 3.8% 6.5% -0.1%

Revenue and income statement

In 2022, CHRONOSOME records a net loss of 2 k€. This deficit will reduce equity on the balance sheet.

EBITDA (2022) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-2 153 €

EBIT (2022) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-2 153 €

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-2 153 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 168%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

168.249%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

62.721%

Repayment capacity (2022) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Solvency indicators evolution
CHRONOSOME

Sector positioning

Debt ratio
168.25 2022
2020
2021
2022
Q1: -2.21
Med: 7.62
Q3: 104.15
Average

In 2022, the debt ratio of CHRONOSOME (168.25) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
62.72% 2022
2020
2021
2022
Q1: 0.05%
Med: 25.74%
Q3: 62.72%
Excellent

In 2022, the financial autonomy of CHRONOSOME (62.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.0 years 2022
2020
2021
2022
Q1: -0.59 years
Med: 0.0 years
Q3: 1.11 years
Good -5 pts over 3 years

In 2022, the repayment capacity of CHRONOSOME (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 159.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

159.23

Interest coverage (2022) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
CHRONOSOME

Sector positioning

Liquidity ratio
159.23 2022
2020
2021
2022
Q1: 89.01
Med: 205.81
Q3: 446.01
Average

In 2022, the liquidity ratio of CHRONOSOME (159.23) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.0x 2022
2020
2021
2022
Q1: -0.02x
Med: 0.0x
Q3: 0.48x
Good -25 pts over 3 years

In 2022, the interest coverage of CHRONOSOME (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
CHRONOSOME

Positioning of CHRONOSOME in its sector

Comparison with sector Autres activités liées au sport

Similar companies (Autres activités liées au sport)

Compare CHRONOSOME with other companies in the same sector:

Frequently asked questions about CHRONOSOME

What is the revenue of CHRONOSOME ?

The revenue of CHRONOSOME in 2021 is 7 k€.

Is CHRONOSOME profitable?

CHRONOSOME recorded a net loss in 2022.

Where is the headquarters of CHRONOSOME ?

The headquarters of CHRONOSOME is located in SAINT-ANDRE (73500), in the department Savoie.

Where to find the tax return of CHRONOSOME ?

The tax return of CHRONOSOME is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CHRONOSOME operate?

CHRONOSOME operates in the sector Autres activités liées au sport (NAF code 93.19Z). See the 'Sector positioning' section above to compare the company with its competitors.